How to solve the crisis behind Bribegate for Chinese doctors-Reference-Cited by-同舟云学术

How to solve the crisis behind Bribegate for Chinese doctors

Published:2012-01 Issue:9812 Volume:379 Page:e13-e15
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Yang Zhiping,Fan Daiming

Publisher

Elsevier BV

Subject

General Medicine

Reference10 articles.

1. Anon. China to step up crackdown on bribery in hospitals, medical industry: report. English.xinhuanet.com Nov 17, 2010. http://news.xinhuanet.com/english2010/china/2010-11/17/c_13610555.htm (accessed Nov 17, 2010).

2. Kickbacks from pharmaceutical companies: when is the end?;Pan;China Hospital CEO,2009

3. How would drug kickbacks be allocated?;Wang;Common People,2004

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Competitive Bidding in Drug Procurement: Evidence from China;American Economic Journal: Economic Policy;2024-08-01

2. Where is the money? Insights into China’s post-COVID healthcare corruption-busting campaign;Journal of Public Health Policy;2024-03-28

3. Pharmaceutical Sales Representatives in the United States and China: The Need for Professional Public Space;Health Care Analysis;2021-11-11

4. Ethics in Medicines: Exposing Unethical Practices and Corruption in All Sectors of Medicines Is Essential for Improving Global Public Health and Saving Patients’ Lives;Medicines;2021-09-14

5. Differences between the European Union and United States of America in Drug Regulatory Affairs Affect Global Patient Safety Standards and Public Health Awareness: The Case of Deferasirox and Other Iron Chelating Drugs;Medicines;2021-07-07